Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Emerging Technologies & Paradigms for In Vitro Dx Europe 2024

Emerging Technologies & Paradigms for In Vitro Dx Europe 2024

Conference Chairman

Steve Soper

Steve Soper
Foundation Distinguished Professor; Director, Center of BioModular Multi-scale System for Precision Medicine, Adjunct Professor, Ulsan National Institute of Science & Technology, The University of Kansas

Keynote Speakers

Paul Bohn
Arthur J. Schmitt Professor of Chemical and Biomolecular Engineering and Professor of Chemistry and Biochemistry, University of Notre Dame

Martyn Boutelle
Professor of Biomedical Sensors Engineering, Imperial College London

Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington

Yoon-Kyoung Cho
Professor, Biomedical Engineering, Ulsan National Institute of Science & Technology; Group leader, IBS; FRSC, Fellow of Royal Society of Chemistry

Brian Cunningham
Professor and Intel Alumni Endowed Chair, University of Illinois at Urbana-Champaign

Andrew Godwin
Professor and Division Director, Genomic Diagnostics, Founding Director, Kansas Institute for Precision Medicine, Deputy Director, KU Cancer Center, University of Kansas Medical Center

Adam Hall
Associate Professor of Biomedical Engineering, Wake Forest School of Medicine

Tony Hu
Professor and Weatherhead Presidential Chair, Tulane University School of Medicine

Erik Vollebregt
Partner, Axon Lawyers

David Wong
Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles


SelectBIO is pleased to welcome you to Emerging Technologies and Paradigms for In Vitro Diagnostics Europe 2024 to be held 18-19 March 2024 at the Marriott Rotterdam -- Rotterdam, The Netherlands.

The goal of this conference is to provide a deep dive into the current technical landscape of technologies and approaches for building novel in vitro diagnostics including rapid diagnostics delivered at the point-of-need, point-of-care.

Additionally, we bring together the ecosystem of legal and regulatory framework that together with the technologies being developed sets forth the stage for commercial successes or failures.

Companies are invited to participate and present their technologies, and their offerings to this marketplace.

The conference includes invited presentations, sponsored presentations by companies as well as a co-located exhibit hall for companies to commercially-engage with the conference participants.

There are extensive opportunities for networking and SelectBIO Conferences includes breakfasts, lunches and networking receptions as a means to bring together the participants and foster networking and engagement.

The location of the Marriott Rotterdam is ideal -- right across from Rotterdam Centraal offering fast connections to Amsterdam-Schiphol Airport, Antwerp, Brussels and Paris and the Eurostar to London.

SelectBIO is honoured that Professor Dr. Steve Soper, key opinion leader in the field, is Conference Chairperson.

Agenda Topics

  • Circulating Biomarkers: cfDNA, RNA, EVs, Others
  • Developed Diagnostics Tests -- Cancer Mutation Testing, and Diseases Beyond Cancer Such as CVD and CNS Diseases
  • Emerging Point-of-Care Diagnostics (POC) Technologies
  • Emerging Technologies for Developing Dx: Surface-Enhanced Raman, Plasmonics, and Others
  • Liquid Biopsy in 2024 -- Status Update
  • Screening for Early Disease Detection

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager

Distinguished Faculty

Rebecca Whelan, Associate Professor of Chemistry, University of Kansas
Hyungsoon Im, Associate Professor, Center for Systems Biology, Mass General Hospital (MGH)/Harvard Medical School
Jaebum Choo, Professor, Chung-Ang University

Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks